Related Experiment Video
Updated: Aug 13, 2026
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Gene therapy for malignant gliomas
1Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, USA.
Abstract:
Malignant gliomas are attractive targets for gene therapy because of their relatively well-localized distribution. Several new strategies have been devised that target different aspects of glioma biology. Gene transfer can be used to synthesize chemotherapy drugs that block DNA synthesis within these highly mitotic tumors. New genes can be introduced that restore the functions of mutated tumor suppressor genes or block the molecular pathways needed for tumor angiogenesis. Alternatively, the immune response to these tumors can be augmented by the local production of cytokines. Finally, viruses themselves can be used as tumoricidal agents by designing viruses that selectively replicate and destroy tumor cells. The advantages and limitations of these approaches are discussed in the context of their possible application to the treatment of these highly lethal malignancies.
Insights
Gene therapy offers promising strategies for treating malignant gliomas by targeting tumor biology. These approaches include synthesizing chemotherapy drugs, restoring tumor suppressor genes, blocking angiogenesis, augmenting immune response, and using tumor-selective viruses.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Malignant gliomas are a significant therapeutic challenge due to their invasive nature.
- Their localized distribution makes them amenable to targeted therapies like gene therapy.
- Existing treatments have limitations, necessitating novel therapeutic strategies.
Purpose of the Study:
- To explore various gene therapy strategies for malignant gliomas.
- To discuss the advantages and limitations of each approach.
- To evaluate the potential application of these strategies in treating gliomas.
Main Methods:
- Gene transfer for chemotherapy drug synthesis.
- Introduction of genes to restore tumor suppressor functions.
- Gene therapy to inhibit tumor angiogenesis.
- Augmentation of immune response via cytokine production.
- Oncolytic virotherapy for selective tumor cell destruction.
Main Results:
- Gene therapy can be designed to block DNA synthesis in rapidly dividing glioma cells.
- Restoring tumor suppressor genes or inhibiting angiogenesis can impede tumor growth.
- Local cytokine production can enhance the anti-glioma immune response.
- Engineered viruses show potential for selective glioma cell lysis.
- Each strategy presents unique advantages and limitations for clinical application.
Conclusions:
- Gene therapy offers a versatile platform for targeting malignant gliomas.
- Multiple gene-based approaches demonstrate potential for treating these lethal brain tumors.
- Further research is needed to optimize and translate these strategies into effective clinical treatments.
More Related Videos
Related Concept Videos
00:59Gene Therapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...